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Background: The aim of present study is to determine the long-term results of patients who 
undergo pars plana vitrectomy after retained nucleus into the vitreous.
Setting: Service of Ophthalmology, Hospital Universitari St Joan, Reus (Barcelona), Spain.
Methods: Retrospective, noncomparative, consecutive case series. Medical records were 
reviewed of all patients who underwent pars plana vitrectomy for retained nucleus into the 
vitreous after complicated cataract surgery, over a 9-year period between August 1, 1997 and 
July 31, 2005.
Result: The incidence of retained lens fragments was 0.57% (63 patients), the postoperative 
visual acuity was higher than 20/40 in 59.60% and fell to 48.93% by the end of the study, and 
was related to the presence of CME and retinal detachment. The CME appeared in 31.91% of 
the patients and was related to preoperative uveitis an corneal edema. In the group of patients 
on whom the vitrectomy was performed at the time of cataract complication, visual acuity was 
higher than 20/40 in 77.77%, and no one developed secondary glaucoma or uveitis.
Conclusion: Being retrospective, our study was not result conclusive. Despite the initial good 
results of these patients after PPV surgery, follow-up should be accurate and over a long period 
of time in order to minimize postoperative complications such as retinal detachment, retinal 
breaks, secondary glaucoma and CME.
Keywords: Nucleus loss, retained lens fragment, incidence of retained lens fragments, pars 
plana vitrectomy, phacoemulsiﬁ  cation, cystoid macular edema
Background
Posterior dislocation of the lens into the vitreous cavity is a rare but major complica-
tion of cataract surgery. The presence of these retained lens fragments may create 
complications such as uveitis, corneal edema, cystoid macular edema (CME) and 
retinal detachment, resulting in a decrease in visual acuity (Monshizadeh et al 1999; 
Kim et al 2002; Yang et al 2002). The incidence of posterior dislocation of the lens 
ranges from 0.3% to 1.1% (Pande et al 1996; Stilma et al 1997; Leaming 2004). It 
has been shown that his rate is inversely related to the experience of the surgeon 
(Schwartz 2002); Aasuri et al (2001) found a rate of 0.2% for experienced surgeons 
against 0.65% for trainees.
Risk factors for lens loss into the vitreous include small papillary size, hard nucleus, 
traumatic cataract, deep-set eyes, pseudoexfoliation syndrome, and patients movement 
during surgery. Although capsular rupture, zonular dehiscence and dislocation of the 
lens into the vitreous can occur during any phase of cataract surgery, it occurs most 
often during grooving and cracking followed by lens emulsiﬁ  cation (Monshizadeh 
et al 1999; Kim et al 2002; Yang et al 2002).
The primary cataract surgeon plays an important role in minimizing the second-
ary complications after lens loss, anterior vitrectomy and removal of residual cortical 
material is recommended. No traumatic maneuvers, such as insertion of lens loop, are Clinical Ophthalmology 2007:1(4) 506
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indicated, and we prefer no implantation of intraocular lens 
to be inserted. Finally, tight closure of the corneal wound 
is necessary in order to prevent leakage during pars plana 
vitrectomy (PPV).
Numerous excellent studies have reported prognostic 
indicators and visual outcomes in eyes managed by pars plana 
vitrectomy (PPV). The aim of present study is to determine 
the long-term results of patients who undergo pars plana 
vitrectomy after retained nucleus into the vitreous.
Methods
Design
Retrospective, noncomparative, consecutive case series. 
Medical records were reviewed of all patients who under-
went pars plana vitrectomy for retained nucleus into the 
vitreous after complicated cataract surgery over a nine-year 
period between August 1, 1997 and July 31, 2005. Surgery 
was performed at the Retina Unit of the Ophthalmology 
Service. There was a sample of 47 eyes from 47 patients 
who were referred to our hospital for nucleus loss into the 
vitreous after complicated cataract phacoemulsiﬁ  cation 
(Table 1).
Setting
Unidad de Ophthalmologia, Hospital Universitari de St Joan, 
Reus (Spain), which has a dependent population of 306,520 
for vitreo-retinal surgery.
Diagnostic criteria
The LOCS system III (Chylack LT Jr) was used in the clas-
siﬁ  cation of lens opacities. Corneal edema was considered 
signiﬁ  cant when both stromal and epithelial edema were 
present. Anterior uveitis was graded by the number of cells in 
the anterior chamber (1+ = minimum cells and 4+ = marked 
cells) and the posterior uveitis was graded in order of the 
number of cells present into the vitreous cavity.
Macular edema was deﬁ  ned as pseudophakic cystoid 
macular edema (CME) if the ﬂ  uorescein angiogram revealed 
a typical petaloid pattern of foveal hyperﬂ  uorescence with 
associated typical cystoid pattern in the optical coherence 
tomography, and if no microaneurism or retinal exudates are 
seen in the macular region. From August 1, 1998 to Janu-
ary 1, 2001 the only diagnostic criteria was the ﬂ  uorescein 
angiography, as the OCT has been incorporated as a diag-
nostic criteria since this data (Gass et al 1966; Tranos et al 
2004). Patients included were those with nucleus lens loss 
into the vitreous cavity after cataract surgery performed by 
phacoemulsiﬁ  cation and without intraocular lens implanta-
tion (Table 2).
No patients had had an intraocular lens implanted when 
they came to our Hospital with fragments of the lens nucleus 
that had been lost into the vitreous.
We excluded patients who presented only cortical frag-
ments of the lens without nuclear material (8 patients), 
patients who were not visited in the correct order of visits 
after surgery (4 patients), patients with PPV previous to 
cataract surgery (3 cases), and patients with macular lesions 
such as myopic changes or age-related macular degeneration 
that affects the central visual acuity (1 case) (Table 3).
Patient examination
Patients were referred at varying times after cataract extrac-
tion by the primary cataract surgeons and the vitrectomy 
Table 2 Inclusion and exclusion criteria
Inclusion criteria
Patients with nucleus lens loss into the vitreous cavity after cataract 
surgery made by phacoemulsiﬁ  cation
Exclusion criteria
Patients who present only cortical fragments of the lens without nuclear 
material
Patients who were not visited in the correct order of follow-up after 
surgery
Patients who died during the period of the study
Patients with macular lesions such as myopic changes or age-related 
macular degeneration that affect central visual acuity
Patients with previous PPV, before cataract surgery
Patients with rubeosis iridis or neovascular glaucoma previous to cata-
ract surgery
Patients with previous chronic glaucoma, or optic disc atrophy
Patients with previous history of inﬂ  ammatory episodes (uveitis)
Table 1 Demographic data of the study
 Number/Mean  Percentage/Range
Male/Female 19/28  40.40%/59.60%
Age in years (mean ± SD)  72.89 ± 9.91  (57–86)
Duration of follow-up in   63.27 ± 23.08  (22–106)
months (mean ± SD)
Presence of pseudoexfoliation   19 patients  40.40%
syndrome
Presence of myopia  13   27.70%
Presence of small papillary size  6  12.76%
Presence of diabetes mellitus  12  25.53%
Presence of arterial   22  46.80%
hypertension
Hard nucleus NC5 or NC6 of  22  46.80%
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was undergone within a few days. We measured the time 
between primary cataract surgery and vitreo-retinal interven-
tion according to records in the patients’ history.
A dilated fundus examination was performed preopera-
tively in order to identify the number and location of the lens 
fragments, and to rule out any retinal tears or breaks, in which 
case an argon laser photocoagulation was performed if the 
visualization of the retina was possible. In addition, an IOP 
was taken, and we noted if there were any other pathologies, 
such as vitreous or suprachoroidal haemorrhage, CME or 
previous glaucoma.
After the pars plana vitrectomy, there was a follow-up 
control of the patients at 1 week, 1 month, 3 months and 
every six months thereafter until the end of the study. The 
corrected visual acuity was measured at each control and 
included in the statistical study with the results obtained at 
three months, 6 months and at the end of the study.
If after January 2001 we observed cystoid macular edema 
in the macular area we did a ﬂ  uorescein angiography and 
an optical coherence tomography (OCT). All colour pho-
tographs, ﬂ  uorescein angiograms and OCT images were 
graded by an independent retina specialist, blind to patients 
identity.
At the end of the study all patients were submitted to an 
exploration that included corrected Snellen visual acuity, 
applanation tonometry, corneal pachimetry (with ORB-
SCAN), fundus retinography, ﬂ  uorescein angiography and 
OCT macular exploration.
Surgery
PPV was performed as soon as a vitreo-retinal operating room 
became available. A standard three-port pars plana vitrec-
tomy is the procedure of choice after stability of the cataract 
wound is ensured. Any residual lens material surrounding the 
iris area is carefully removed; care is taken to avoid break-
ing the capsular remains ready for the ﬁ  nal intraocular lens 
implantation. A core vitrectomy was performed, followed by 
the removal of the softer cortical lens material and vitreous 
around the nucleus. A small volume of perﬂ  uorodecaline is 
injected over the optic nerve in order to protect the macular 
area against the ultrasonic energy and mechanical trauma 
from the lens fragments (Greve et al 1993; Movshovich 
1994). The phacofragmatome tip was used to aspirate the 
nucleus material, assisted by the tip of the endoilluminator 
to keep the nuclear fragments near the phacofragmatome; 
we used low power settings in order to elude the propulsion 
of the lens fragments (Monshizadeh et al 1999; Kim et al 
2002; Yang et al 2002).
After the vitrectomy and lensectomy is complete a periph-
eral examination with scleral depression is performed, and 
peripheral vitrectomy is performed in order to eliminate any 
peripheral vitreous traction. If there is any break or tear, an 
argon endolaser treatment is performed.
At the end of the surgery a placement of the IOL is per-
formed. If a small intact capsulorhexis is present the IOL can 
be placed in the sulcus anteriorly. The type of lens used was 
a hydrogel foldable posterior chamber IOL model H60M 
Hydroview® (Bausch and Lomb®). An anterior chamber 
IOL is placed in patients who lack adequate capsular sup-
port. The type of lens used was an AC-IOL model 122UV 
(Bausch and Lomb®) performed by polymethylmethacrylate 
(PMMA) with ﬂ  exible haptics, with an overall lens diameter 
of 12.5 mm.
Variables introduced in the study
The following pre-PPV variables were assessed for their 
association with results: age, gender, time between cataract 
surgery and PPV. We also included in the analysis of risk 
factors the following ﬁ  ndings on presenting clinical exami-
nation: presence of high IOP, corneal edema, uveitis, and 
retinal detachment.
In relation to the time between primary cataract surgery 
and PPV, we classiﬁ  ed patients as those operated on within 
the ﬁ  rst seven days after lens loss, and those on whom 
PPV was performed after seven days. In a second step we 
introduced the patients who underwent PPV at the time of 
cataract primary complicated chirurgical intervention (this 
group included only nine patients).
The statistical analysis to determine risk factors for ﬁ  nal 
visual outcome was performed with all of these variables 
Table 3 Best corrected visual acuity
  Initial examination   3-months postoperative  6-months postoperative  Final examination
  N (%)  visit N (%)  visit N (%)  N (%)
0.5  0 (0)  28 (59.6)  19 (40.4)  20 (42.6)
0.1–0.5  13 (27.6)  10 (21.3)  16 (34.0)  14 (29.8)
0.1  34 (72.4)  9 (19.1)  12 (25.6)  13 (27.7)Clinical Ophthalmology 2007:1(4) 508
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plus the following post-operative variables: post-vitrectomy 
retinal detachment, CME at any time during the follow-up, 
post-operative inﬂ  ammation, and type of intraocular lens 
implantation: anterior chamber lens (AC-IOL) or sulcus 
intraocular lens (SC-IOL).
Statistical analysis
In this study, no all variables assessed as risk factors had 
data missing. If any variable was not recorded, the patient 
was excluded from the study.
Descriptive statistics were created using SPSS statisti-
cal software (version 13.0). Values are expressed as mean 
±SD, and statistical signiﬁ  cance was determined using the 
Student’s t-test for paired data. We used the Student’s paired 
test to compare the quantitative data. Best-corrected acuities 
were converted to Log-MAR values to allow for statistical 
analysis. The McNemar test was used for evaluating the 
qualitative data such as presence of the CME, corneal edema, 
retinal detachment, high IOP etc.
We did a logistical regression analysis to study the 
relationship between ﬁ  nal visual acuity, considering the 
following risk factors: Gender, cystoid macular edema, 
corneal edema, presence of previous high IOP, uveitis, AC 
intraocular lens, and timing between the primary cataract 
surgery and the VPP.
In all cases, p =  0.05 and the odds ratio had a conﬁ  dence 
interval of 95%.
Results
Incidence of retained lens fragments
In the period of study the referral centres had performed 
10,929 cataracts operations and 63 patients were referred to 
our centre after primary cataract surgery complications, an 
incidence of 0.57%.
Demographic data
All 47 patients (28 (59.60%) women and 19 (40.40%) men) 
completed the study and the mean follow-up of the patients 
was 63.27 ± 23.08 (12.00 to 106.00) months after surgery. 
Mean age was 72.89 ± 9.91 (57 to 86) years, diabetes 
appeared in 12 patients (25.53%), and arterial hypertension 
was present in 22 patients (46.80%).
Pseudoexfoliation syndrome was present in 19 patients 
(40.40%), myopia in 13 patients (27.70%), and small pupillary 
size with bad midriasis was observed in 6 patients (12.76%). 
The presence of lens subluxation was observed in 4 patients 
(8.50%) during primary cataract surgery, and yatrogenic intra-
operative maneuvers was reported in 10 patients (21.27%).
On the basis of the LOCS III classiﬁ  cation system of 
cataracts, the presence of hard nucleus (NC5 or NC6) was 
detected in 22 patients (46.80%).
Preoperative PPV data
Six patients (12.80%) lost the nucleus into the vitreous at 
hydrodissection, 24 patients (51.10%) at grooving and crack-
ing, and 17 patients (36.20%) at emulsiﬁ  cation .
The IOP was high in 31 patients before PPV (66.00%), 
corneal edema was present in 28 patients (59.60%) and 
uveitis in 14 patients (29.80%). In one patient (2.12%) we 
observed anterior suprachoroidal hemorrhage. We did not 
observe any cases of retinal detachment or vitreous hemor-
rhage.
Intraoperative data
We performed pars plana vitrectomy in all eyes and did not 
observe any intraoperative complications in any patient.
In 7 patients (14.89%) we observed retinal breaks or tears 
in the periphery, so we performed intraoperative argon laser 
photocoagulation. Between 3 and 9 hours ﬁ  ve breaks were 
located in the inferior retina and 2 in the superior retina.
At the end of surgery we implanted an anterior chamber 
IOL into 21 patients (44.68%), and a sulcus IOL into 26 
patients (55.32%).
Postoperative complications data
We observed the presence of postoperative retinal detachment 
in 3 patients (6.40%) and all cases appeared within the ﬁ  rst 
2 months after PPV surgery. In the postoperative period we 
observed 6 patients (12.76%) who developed retinal breaks 
or tears 4.18 ± 1.33 months after PPV surgery. Between 3 
and 9 hours ﬁ  ve breaks were located in the superior retina 
and one in the inferior retina.
No postoperative complications, such as vitreous or 
suprachoroidal haemorrhage or fibrinous uveitis were 
recorded. One patient with sulcus IOL implantation presented 
a subluxation of the IOL 3 weeks after surgery and needed a 
new PPV and an exchange of the IOL for an AC-IOL.
Glaucoma persisted in 12 patients (25.53%) after PPV, 
and need antiglaucomatous topical treatment. Secondary 
glaucoma is more frequent in patients with AC-IOL (11/21 
patients (52.38%)) than in patients with sulcus implanted 
IOL (9/26 patients (34.61%)). Two patients with AC-IOL 
developed bullous keratopathy after PPV, one patient three 
years and the other 4 years after surgery.
During the ﬁ  rst 6 months after surgery, a CME appeared in 
15 patients (31.91%), which was resolved in 13 of them with Clinical Ophthalmology 2007:1(4) 509
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topical treatment. Treatment was with topical prednisolone 
acetate and with topical cyclooxygenase inhibitor (COI). The 
COI used was diclofenac. The other two patients who had not 
recovered were given a sub-Tenon’s triamcinolone injection, 
but both developed a chronic form of CME. In 6/13 patients 
who recovered after their ﬁ  rst CME crisis, the CME relapsed 
during the six months follow-up. Treatment with predniso-
lone + diclofenac was initiated and three patients were given 
a sub-Tenon’s triamcinolone injection. Of these six patients, 
two recovered and four developed a chronic CME. At the end 
of the study, we observed a chronic cystoid macular edema 
had formed in six patients (12.76%)
Postoperative visual acuity
The mean corrected visual acuity in the Snellen chart, at three 
months after surgery was 0.63 ± 0.28 (0.05 to 1). At the end 
of the study the mean was 0,59 ± 0,29 (0.05 to 1).
At three months postoperatively, 28 patients (59.6%) had 
a corrected visual acuity of over 0.5, and 9 patients (19.1%) 
had vision 0.1.
Visual acuity was over 0.5 in 23 patients (48.93%) at the 
end of the study. In 13 patients (27.65%) visual acuity was 
0.1 0,10,10.
Statistical analysis of ﬁ  nal visual acuity 
(Table 4)
In the univariate analysis of risk factors, we observed 
that ﬁ  nal visual acuity under 20/40 is correlated to the 
presence of CME (p  0.001), the postoperative retinal 
detachment (p  0.001), surgery later than seven days 
(p = 0.002), the presence of corneal edema (p =  0.005), 
and high preoperative IOP (p = 0.050). In the logistical 
regression analysis, we may observe that only the presence 
of CME (p = 0.003) and retinal detachment (p = 0.002) were 
signiﬁ  cant risks factors.
Statistical analysis of the cystoid macular 
edema (Table 4)
In the univariate analysis only the time between the two oper-
ations (p  0.001), the presence of uveitis in the preoperative 
period (p = 0.001) and corneal edema (p = 0.005) were 
statistically signiﬁ  cant risk factors. In the logistical regression 
analysis only preoperative uveitis (p = 0.011) and corneal 
edema (p = 0.034) were signiﬁ  cant risk factors.
Statistical analysis of results of PPV performed at the 
time of phacoemulsiﬁ  cation (Table 5).
In nine patients, PPV was performed immediately after 
lens loss, with ﬁ  nal visual acuity being better in this group 
of patients. Seven of the nine had a ﬁ  nal visual acuity over 
20/40 (77.77%). None of these patients had uveitis or high 
IOP, and no patients developed secondary glaucoma. More-
over, the development of CME post-operative appeared in 
only one patient (11.11%). The application of McNemar test 
is signiﬁ  cant for all risk factors studied except. Gender, the 
presence of corneal edema and AC-IOL.
In the logistical regression analysis the postoperative 
uveitis, secondary glaucoma, CME development and retinal 
detachment beneﬁ  t from PPV at the time of primary cataract 
surgery.
Discussion
Several studies describing the clinical course of patients 
who had PPV for retained lens fragments show that most 
postoperative complications included glaucoma, retinal 
detachment, endophthalmitis and cystoid macular edema. 
Also, a lot of controversy persists in these studies about the 
timing of vitrectomy after the primary cataract surgery.
The visual acuity of eyes that have undergone PPV 
has improved since the earlier reports, which showed a 
ﬁ  nal visual acuity better than 0.5 in 42% (Blodi et al 1992; 
Gilliland et al 1992; Kim et al 1994; Borne et al 1996). More 
Table 4 Statistical analysis of the ﬁ  nal corrected visual acuity and cystoid macular edema in respect of the studied risk factors
  Final visual acuity   Cystoid macular edema
  Univariate analysis  Logistic regression  Univariate analysis  Logistic regression
  P value  IC interval  P value  IC interval  P value  IC interval  P value  IC interval
   95%   95%   95%   95%
Gender 0.676  0.492–1.581  0.246  0.326–78.339  0.309  7.63  ± 0.92  0.483  0.240–20.463
High IOP   0.050  1.022–3.086  0.310  0.186–22.135  0.334  11/73  0.232  0.396–45.731
Surgery timing  0.002  1.318–5.120  0.628  0.023–9.646  0.001 6/38  0.259  0.380–36.458
Corneal  edema  0.005 1.256–4.183  0.088 0.002–1.535 0.005 11/87  0.034 2.80–15.66
Uveitis  0.587 0.603–2.395  0.204 0.331–79.254  0.001 13/78  0.011 2.073–36.828
Retinal detachment  0.001  0.320–6.636  0.002 0.229–7.254 0.338 0.667–1.739  0.677 0.112–33.220
Postoperative CME  0.001 1.888–26.893 0.003  0.000–10.072       
AC-IOL  0.671 0.492–1.577  0.104 0.623–66.834  0.093 0.667–1.739  0.719 0.203–10.092Clinical Ophthalmology 2007:1(4) 510
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recently, studies have reported ﬁ  nal visual acuity better than 
0.5 in 60%–68% (Oruc 2001; Rossetti et al 2002; Scott et al 
2003) of the patients. Our results show 59.60% of patients 
with vision 0.5 or higher, but we should take into account that 
we have seen changes over time. In the course of the study, 
visual acuity has decreased and the ﬁ  nal visual acuity higher 
than 0.5 was achieved by only 42.60% of the patients. The 
major decrease was observed in the six months postopera-
tive period, a possible explanation being that during the ﬁ  rst 
six months postoperative period CME appeared and many 
patients suffered a decrease in their vision that many cannot 
recover. This ﬁ  nding is similar to Greven et al (2004).
In all published studies, the most serious threat to vision 
is retinal detachment. An extensive study by Moore et al 
(2003) described a preoperative rate of RD of 7.3%, contrary 
to the results of this study, which had no patients with RD 
before PPV. This ﬁ  nding is not exceptional and in the litera-
ture there are other authors with similar ﬁ  ndings (Kapusta 
et al 1996; Stilma et al 1997). Preoperative RD is a major 
risk factor related to the manipulation of vitreous during the 
primary cataract surgery, therefore correct postoperative care 
of cataracts may decrease the risk. In our study, RD after PPV 
appeared in 6.40% of patients, and appeared within the two 
months after surgery. These ﬁ  ndings were similar to those 
of other authors, who found a 3.5%–9% rate of RD (Borne 
et al 1996; Kapusta et al 1996; Olsson et al 2000; Oruc et al 
2001; Moore et al 2003).
The authors think that the scrupulous exploration of the 
periphery during vitrectomy and in the postoperative follow-
up is important. In fact, we encountered breaks and tears 
in 7 patients (14.89%) during the PPV surgery, and in the 
postoperative follow-up in 6 patients (12.76%) who needed 
argon laser photocoagulation, appearing 4.18 ± 1.33 months 
after PPV surgery. We should, therefore, observe the patients 
carefully in the postoperative period because the rate of new 
retinal breaks or retinal detachment is high in this type of 
patient. It is interesting that in the preoperative period the 
majority of breaks are located inferiorly, opposite to the 
limbal incision at the cornea, a ﬁ  nding which suggests that 
the etiology may be related to the vitreous traction on the 
peripheral retina during removal of dislocated fragments 
toward the corneal incision.
In the postoperative period a major visual decrease is 
attribute to the cystoid macular edema (Cohen et al 2006). 
In the present study CME is the major cause of visual 
impairment, but there are several important considerations 
when studying eyes with CME after PPV for retained lens 
nucleus. Because CME can occur several months after sur-
gery, adequate follow-up is important (Nelson 2003; Tranos 
et al 2004). In our study ﬁ  fteen patients (31.91%), suffered 
CME in the ﬁ  rst six months of the PPV, and we should take 
into account that in six patients (12.76%) the CME has still 
not been resolved 4.56 ± 1.34 years later and continues as a 
chronic problem.
The appearance of postoperative secondary glaucoma in 
the present study (25.53%) is similar to other studies (Vilar 
et al 1997; Yang et al 2002; Hansson et al 2002). It is worth 
noting that in patients with AC-IOL, the rate of glaucoma is 
higher than in those with sulcus implanted IOL. Also, second-
ary complications to the implantation of AC-IOL included 
two patients who presented bullous keratopathy that needed 
IOL exchange. We are not surprised by these complications 
because these types of patients had suffered traumatic pri-
mary cataract surgery, which decreases the rate of endothelial 
cells in the cornea. An alternative to CA lens implantation 
may be the scleral-sulcus sutured lens, but we have never 
performed this type of lens implantation in our centre.
Many authors have reported that the time between lens 
loss in the vitreous and the vitrectomy surgery is not a risk 
factor to ﬁ  nal visual acuity (Monshizadeh et al 1999; Scott 
Table 5 Statistical analysis of the ﬁ  nal corrected visual acuity in respect of the studied risk factors, in patients in who the PPV was 
performed at the time of the complicated primary cataract surgery
 Univariate  analysis    Logistic  regression
  P value  IC interval  P value  IC interval
   95%  95%
Gender 0.676  0.034–2.133  0.295  0.026–3.027
Surgery timing  0.001 3.318–15.120  0.001 1.224–13.323
Corneal  edema  0.465 0.355–1.893  0.609 0.067–2.658
Uveitis  0.002 0.936–1.986  0.022 0.988–11.232
Postoperative CME  0.001 2.599–28.781  0.031  1.233–10.761
Secondary glaucoma  0.001 4.718–30.138  0.024  1.221–9.223
Retinal detachment  0.001 0.983–27.331  0.002  0.877–11.225
AC-IOL  0.180 0.444–5.010  0.089 0.696–4.945Clinical Ophthalmology 2007:1(4) 511
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2001; Kim et al 2002; Kwok 2002; Yang et al 2002). In the 
present study, we have classiﬁ  ed those patients who had PPV 
within seven days of the primary cataract surgery, and those 
who were operated on after seven days, and the results of 
the Logistic Regression analysis show that timing is not a 
risk factor, despite the fact that the univariante analysis by 
applying the McNemar test shows that it is.
In spite of having a small group of patients (nine) on 
whom we could perform the PPV at the time of primary 
cataract surgery, ﬁ  nal visual acuity in this group is better than 
in the others patients, with 77.77% of patients having vision 
higher than 0.5. Also this group developed CME in only one 
case (11.11%) and secondary glaucoma did not appear after 
surgery. These ﬁ  ndings are similar to Kageyama et al (2001) 
and Kim et al (Kim JE et al 1994). The clinico-pathological 
correlation by Yeo et al (1999) found a signiﬁ  cant correlation 
between the number of the inﬂ  ammatory cells in the vitreous 
and the timing of the vitrectomy.
The few cases in this group does not allow us to rec-
ommend deﬁ  nitively PPV in the event of cataract surgery 
complications, and we should take into account that informed 
consent of cataract surgery does not ordinarily include 
the consent for PPV, so the surgeon would have to inform 
the patient while in the operating room, and familiarize the 
patient of the procedure. Furthermore, anesthesia used in 
the primary cataract surgery may make the PPV difﬁ  cult, 
particularly with topical anesthesia.
Being retrospective, our study was not result conclusive, 
despite the initial good results of these patients after PPV 
surgery, so follow-up should be accurate and continued, 
in order to minimize postoperative complications such as 
retinal detachment, retinal breaks, secondary glaucoma 
and CME.
Reports of clinical studies
None of the authors has a ﬁ  nancial or proprietary interest in 
any material or method mentioned.
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